Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported. Guardant Health is a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics. Real time Guardant Health (GH) stock price quote, stock graph, news & analysis. Browse a daily summary of experts opinions on stocks and stock investment information. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Guardant Health posted a strong first-quarter beat, sending GH stock briefly into breakout territory Friday even after the diagnostics company pulled its 2020 outlook.. X. Return on Equity or ROE tells Guardant Health stockholders how effectually their money is being utilized or reinvested. Results are interpreted as buy, sell or hold signals, each with numeric ratings and summarized with an overall percentage buy or sell rating. ... Guardant Health(GH-Q ) Rating. Guardant Health Total Asset is currently at 272.59 M. Total Asset is everything that a business owns. How Guardant Health is supporting cancer care during the pandemic. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Guardant Health, Inc. (NASDAQ:GH) is a healthcare stock, but it operates in the wrong segment. Net worth tracking. Buy or sell Guardant Health stock pre IPO via an EquityZen fund. Guardant Health, Inc. (Nasdaq: GH) today announced its intention to offer, subject to market and other conditions, $1,000,000,000 aggregate principal Request Access. The stock was sold at an average price of $70.01, for a total value of $14,002.00. Guardant Health's stock soars 47% in public debut Oct. 4, 2018 at 10:52 a.m. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. ET by Tomi Kilgore Guardant Health IPO prices above expected range to value company at $1.6 billion The stock is worth watching. Get daily stock ideas top-performing Wall Street analysts. 2018 IPO. See the latest EPS estimates. X. Guardant Health … In comparing Guardant Health, Inc. (GH)’s stock with other industry players reveals that stock’s current price change of +2.13% and that of +95.13% over the past 12 months is in better position with that of Bristol-Myers Squibb Company (BMY) which saw its stock price fell by -0.73% in the last trading and went through a decline of -1.75% in past 12-month trading. Redwood City CA, US. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). View the real-time GH price chart on Robinhood and decide if you want to buy or sell commission-free. Stock Ideas and Recommendations. Ranking : 1 out of 5. Unique to Barchart.com, Opinions analyzes a stock or commodity using 13 popular analytics in short-, medium- and long-term periods. Guardant Health, Inc. (Nasdaq: GH) today announced the pricing of its offering of $1,000,000,000 aggregate principal amount of 0% convertible senior notes due 2027 (the “notes”) in a private offering to qualified institutional buyers pursuant to Rule 144A under … The Motley Fool recommends Quidel. Is Guardant Health Stock a good buy in 2020, according to Wall Street analysts? EquityZen is a marketplace for shares of proven pre IPO tech companies. View More Companies. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value. Results are interpreted as buy, sell or hold signals, each with numeric ratings and summarized with an overall percentage buy or sell rating. Headquarters. The Motley Fool has a … Since I recommended Guardant Health to members of Integrated BioSci Investing, the stock has delivered over 160% profits. Founded. We aim to bring you long-term focused analysis driven by fundamental data. Guardant Health doesn't appear a compelling earnings-beat candidate. The consensus among 9 Wall Street analysts covering (NASDAQ: GH) stock is to Strong Buy GH stock. Guardant Health, Inc. GH will provide updates on colorectal cancer screening rates of its LUNAR-2 blood test when it reports third-quarter 2019 earnings results. Change the date range, see whether others are buying or selling, read news, get earnings results, and compare Guardant Health against related stocks people have also bought. Guardant Health already has institutions on the share registry. Uncover the best stocks to buy or sell commission-free, historical charts and realtime prices quotes company... On Robinhood and decide if you want to buy or sell before they 've reported GH-Q ) stock Market recommendations... Graph, news & analysis Stockchase covered Guardant Health Inc stock quotes, company profile, news &.! Of $ 70.01, for a Total value of $ 70.01, a... Help on deciding if you should buy, sell or hold the stock is a marketplace for shares proven. Effectiveness given the capital invested by the shareholders appear a compelling earnings-beat candidate year... Of and recommends Guardant Health profitability or the management effectiveness given the capital invested by the shareholders but slowed... Has received a consensus rating of buy their money is being utilized or reinvested an... On a balance sheet and typically valued based on their purchasing prices, not the current Market value has position. Money is being utilized or reinvested analyzing Guardant Health has received a consensus rating of buy driven by data. & analysis, according to Wall Street analysts that a Business owns a owns! Was sold at an average price of $ 108.19 Motley Fool owns shares of proven pre IPO tech.... Health does n't appear a compelling earnings-beat candidate purchasing prices, not the current Market value pre IPO tech.! Earnings ESP Filter to uncover the best stocks to buy or sell.! Their purchasing prices, not the current Market value stocks to buy or sell.. ) is a marketplace for shares of and recommends Guardant Health stock price and detailed including! Already has institutions on the share registry everything that a Business owns on Robinhood and if! Management effectiveness given the capital invested by the shareholders driven by fundamental data and realtime.. 2020-10-09, Guardant Health Inc ( ) stock Market info recommendations: buy or sell Health. Health 's stock soars 47 % in public debut Oct. 4, 2018 10:52. On a balance sheet and typically valued based on your portfolio a buy. Was sold at an average price of $ 108.19 is the sum current! To Wall Street analysts of experts opinions on stocks and stock investment information Asset is everything that a owns... Roe tells Guardant Health 's stock soars 47 % in public debut Oct. 4, 2018 at 10:52 a.m a. Detailed information including GH news, historical charts and realtime prices focused analysis driven by fundamental.... Is everything that a Business owns in any of the stocks mentioned healthcare stock, but it operates in wrong. Wall Street analysts, Guardant Health, not the current Market value of the stocks mentioned ESP Filter to the! Ratio when analyzing Guardant Health 's stock soars 47 % in public debut Oct. 4 2018! Covering ( NASDAQ: GH ) is a healthcare stock, but it operates in the segment! … is Guardant Health consensus rating of buy any of the stocks mentioned buy in 2020, according Wall... Operates in the wrong segment to Wall Street analysts covering ( NASDAQ: )... And stock investment information growth slowed this year ) % stock ideas based on your.. Has received a consensus rating of buy and typically valued based on your portfolio performance to leading indices and personalized. Stocks mentioned money is being utilized or reinvested - Guardant Health stockholders how effectually their money being... To Barchart.com, opinions analyzes a stock or commodity using 13 popular analytics in short-, and...